慢性乙型肝炎和肝硬化患者血清HBV基因型分析

doi:10.3969/j.issn.1672-5069.2021.01.023

实用肝脏病杂志 ›› 2021, Vol. 24 ›› Issue (1): 87-90.doi: 10.3969/j.issn.1672-5069.2021.01.023

慢性乙型肝炎和肝硬化患者血清HBV基因型分析

宋金云, 王建芳, 赵宏宇

210003 南京市南京中医药大学附属南京医院/南京市第二医院临床科研中心(宋金云,赵宏宇);
精准医学中心(王建芳)

出版日期:2021-01-10 发布日期:2021-01-19
通讯作者: 宋金云,女,31岁,硕士研究生,助理研究员。主要从事肝炎分子生物学相关研究。E-mail: chuzhou.19890211@163.com
通讯作者:赵宏宇,E-mail:zhysjy2020@163.com
作者简介:宋金云,女,31岁,硕士研究生,助理研究员。主要从事肝炎分子生物学相关研究。E-mail: chuzhou.19890211@163.com
基金资助:
南京市科学技术委员会科技计划项目(编号:201803002)

Hepatitis B viralgenotypes in patients with chronic hepatitis B and cirrhosis

Song Jinyun, Wang Jianfang, Zhao Hongyu

Clinical Research Senter, Second Hospital, Nanjing University of Chinese Medicine, Nanjing 210009, Jiangsu Province, China

Online:2021-01-10 Published:2021-01-19

摘要/Abstract

摘要： 目的分析慢性乙型肝炎和肝硬化患者血清乙型肝炎病毒(HBV)分型分布情况。方法 2015年6月～2018年5月南京中医药大学附属南京市第二医院就诊的慢性乙型肝炎患者261例,乙型肝炎肝硬化患者30例,肝细胞癌4例,采用测序法检测血清HBV基因型。结果在295例HBV感染者中,有132例(44.7%)为B型感染,161例(54.6%)为C型感染,2例(0.7%)为D型感染;慢性乙型肝炎患者与肝硬化患者血清TBIL、ALT和AST水平比较差异均无统计学意义(P>0.05);肝硬化患者血清肝纤维化指标(P<0.05)、血清HBV DNA载量(P<0.05)和血清HBeAg阳性率(x²=5.798,P<0.05)均显著高于慢性乙型肝炎患者;乙型肝炎肝硬化患者和肝细胞癌患者C型感染比例均显著高于慢性乙型肝炎患者,差异具有统计学意义(P<0.05)结论慢性乙型肝炎和肝硬化患者HBV感染以B基因型和C基因型为主,而肝硬化患者以C型感染居多,提示C型感染患者可能比B型患者更容易出现严重的肝损伤,并产生严重的临床结局。

关键词: 肝硬化, 慢性乙型肝炎, 乙型肝炎病毒, 基因分型

Abstract: Objective To investigate the distribution of hepatitis B viral genotype in patients with chronic hepatistis B (CHB) and liver cirrhosis (LC). Methods 261 patients with CHB, 30 with LC and 4 with hepatocellular carcinoma (HCC) were recruited in this study, and HBV genotypes were determined by DNA sequencing. Results Among the 295 HBV infected patients, 132 (44.7%) were with genotype B infection, 161 (54.6%) were with genotype C infection, and 2 (0.7%) were with genotype D infection; 7 positive patterns of HBV serological markers were found in our series, and there were no significant differences with respect to serum bilirubin, ALT and AST between patients with CHB and patients with LC (P>0.05); the indexes of liver fibrosis(P<0.05), serum HBV DNA loads (P<0.05)and serum HBeAg positive rate(x²=5.798,P<0.05) in patients with cirrhosis were significantly higher than those with chronic hepatitis B; te proportions of genotype C in patients with LC and HCC were higher than that in patients with CHB(P<0.05).Conclusions The prevalence of HBV genotypes in patients with CHB and LC are predominantly genotype B and C, and the genotype C infections might lead to severe clinical outcomes.

Key words: Liver cirrhosis, Hepatistis B, Hepatistis B virus, Genotype

宋金云, 王建芳, 赵宏宇. 慢性乙型肝炎和肝硬化患者血清HBV基因型分析[J]. 实用肝脏病杂志, 2021, 24(1): 87-90.

Song Jinyun, Wang Jianfang, Zhao Hongyu. Hepatitis B viralgenotypes in patients with chronic hepatitis B and cirrhosis[J]. Journal of Practical Hepatology, 2021, 24(1): 87-90.

参考文献

[1] Chen L, Shi Y, Yang WR, et al. Differences in Cpg island distribution between subgenotypes of the hepatitis B virus genotype. Med Sci Monit,2018,24:6781-6784.
[2] 张欢欢, 杨欢, 沈思兰, 等.慢性乙型肝炎患者HBV基因型分布及其耐药基因突变分析.实用肝脏病杂志,2019,22(1):41-44.
[3] Li HM, Wang JQ, Wang R, et al. Hepatitis B virus genotypes and genome characteristics in China. World J Gastroenterol,2015,21(21):6684-6697.
[4] We DH, Liu HZ, Huang AM, et al. A new trend of genotype distribution of hepatitis B virus infection in southeast China (Fujian),2006-2013. Epidemiol Infect, 2015,143(13):2822-2826.
[5] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版). 中华肝脏病杂志,2015,23(12):888-905.
[6] Velkov S, Ott JJ, Protzer U, et al. The global hepatitis B virus genotype distribution approximated from available genotyping data. Genes,2018,9(10):E495.
[7] Kim HS, Chen X, Xu M, et al. Frequency ofhepatitis B surface antigen variants(HBsAg) in hepatitis B virus genotype B and C infected east- and southeast Asian patients: detection by the elecsys HBsAg II assay. J Clin Virol,2018,103:48-56.
[8] Zhang Q, Liao Y, Chen J, et al. Epidemiology study of HBV genotypes and antiviral drug resistance in multi-ethnic regions from western China. Sci Rep,2015,5:17413.
[9] Kmet Lunacek N, Poljak M, Maticic M.Distribution of hepatitis B virus genotypes in Europe and clinical implications: a review. Acta Dermatovenerol Alp Pannonica Adriat,2018,27(3):141-146.
[10] Shen YY, Hou W, Yang ZQ, et al. Hepatitis B virus infection and genotype in asymptomatic people from 10 ethnic groups in Yunnan, China. World J Gastroenterol,2015,21(44):12586-12592.
[11] Lin CL, Kao JH. Hepatitis B virus genotypes and variants. Cold Spring Harb Perspect Med,2015,5(5):a021436.
[12] Liu Y, Zhang L, Zhou JY, et al. Clinical and virological characteristics of chronic hepatitis B patients with coexistence of HBsAg and anti-HBs. PLoS One,2016,11(1):0146980.
[13] Huang R,Xia J,Liu Y,et al. Acoustic radiation force impulse in the diagnosis of liver fibrosis in patients with chronic hepatitis B. Eur J Gastroenterol Hepatol,2017,29(8):980-981.
[14] Wang ZF,Wang MY,Yu DH,et al. Therapeutic effect of chitosan on CCl4 induced hepatic fibrosis in rats. Mol Med Rep,2018,18(3):3211-3218.
[15] Liao Y, Gong J, Zhou W,et al. Serum liver fibrosis markers discriminate significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase. J Med Virol,2019,91(4):642-649.
[16] Chen P, Xie Q, Lu X, et al.Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA: a community-based study. Medcine (Baltimore),2017,96(33): e7766.
[17] 王明, 张抒, 李明, 等.慢性乙型肝炎患者血清与粪便HBV DNA水平对比研究. 实用肝脏病杂志,2019,22(2):176-179.
[18] Lin CL, Kao JH. Natural history of acute and chronic hepatitis B: the role of HBV genotypes and mutants. Best Pract Res Clin Gastroenterol,2017,31(3):249-255.
[19] 伍宵, 魏少峰, 徐楠, 等.中国慢性HBV感染者基因型分布及临床意义Meta分析.实用肝脏病杂志,2017,20(3):271-275.
[20] Tian Q, Jia J. Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia. Hepatol Int,2016,10(6):854-860.

慢性乙型肝炎和肝硬化患者血清HBV基因型分析

Hepatitis B viralgenotypes in patients with chronic hepatitis B and cirrhosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	郑志恒, 李维筠, 回振宇, 陈莹. 聚乙二醇干扰素α-2a联合恩替卡韦治疗慢性乙型肝炎患者疗效及血清Pygo2和GP73水平变化[J]. 实用肝脏病杂志, 2021, 24(1): 19-22.
[2]	吴冬秋, 崔丽华, 熊峰, 邬政宏. 血清IL-34联合超声弹性成像诊断慢性乙型肝炎患者肝纤维化的效能分析[J]. 实用肝脏病杂志, 2021, 24(1): 23-26.
[3]	林金祥, 杨可立. PEG-IFNα-2a与PEG-IFNα-2b治疗慢性乙型肝炎患者疗效研究[J]. 实用肝脏病杂志, 2021, 24(1): 27-30.
[4]	魏荣荣, 李爱玲, 李红, 张缭云. 慢性肝炎肝硬化和肝衰竭患者吲哚菁绿清除试验的变化及其临床意义[J]. 实用肝脏病杂志, 2021, 24(1): 91-94.
[5]	张昕, 郭悦, 杨军. 瞬时弹性成像测定肝脾硬度值评估乙型肝炎肝硬化患者食管静脉曲张初步研究[J]. 实用肝脏病杂志, 2021, 24(1): 95-98.
[6]	范静, 徐静, 袁雪. 利福昔明联合乳果糖治疗肝性脑病患者疗效及其血清S100B蛋白和神经元特异性烯醇化酶变化[J]. 实用肝脏病杂志, 2021, 24(1): 103-106.
[7]	叶晓婷, 孙庆丰, 付荣泉, 洪亮, 周宇, 张伟伟. 瞬时弹性成像技术评估替诺福韦联合扶正化瘀胶囊治疗乙型肝炎肝硬化患者疗效初步研究[J]. 实用肝脏病杂志, 2021, 24(1): 143-144.
[8]	方奕, 陈毅雄, 裴冬萍, 操银针. 恩替卡韦联合复方嗜酸乳杆菌治疗CHB合并NAFLD患者疗效及其对血清相关酶系的影响[J]. 实用肝脏病杂志, 2020, 23(5): 634-637.
[9]	吴雄飞, 方利娟, 陈艳. 替诺福韦联合干扰素-α治疗HBeAg阳性慢性乙型肝炎患者疗效及其血清细胞因子水平变化[J]. 实用肝脏病杂志, 2020, 23(5): 638-641.
[10]	张浩, 常建东, 陈小燕. 超声弹性成像结合血清学指标诊断慢性乙型肝炎患者肝纤维化价值评价[J]. 实用肝脏病杂志, 2020, 23(5): 642-645.
[11]	曾艳妮, 韩军, 刘良进, 秦涛, 毕俊英. 不同Child-Pugh分级的血吸虫病性肝硬化患者肝脏CT灌注成像参数分析[J]. 实用肝脏病杂志, 2020, 23(5): 691-694.
[12]	杨熹, 宋冬梅, 华敏. 生长抑素联合奥曲肽治疗肝硬化并发上消化道出血患者疗效及其对凝血功能指标的影响再观察[J]. 实用肝脏病杂志, 2020, 23(5): 695-698.
[13]	扈登财, 杜莉, 曹成红, 史晋洁, 李亚宁. 血清降钙素原和C-反应蛋白水平预测肝硬化患者发生自发性细菌性腹膜炎的价值分析[J]. 实用肝脏病杂志, 2020, 23(5): 699-702.
[14]	陆长春, 丁敏侠, 段作斌, 蔺咏梅. LAM和ADV长期联合后转换为替诺夫韦治疗乙型肝炎肝硬化患者疗效及其对肾功能的影响[J]. 实用肝脏病杂志, 2020, 23(5): 703-706.
[15]	贺连栋, 曹淑琴, 韩灿, 陈有玺. 腹水浓缩回输治疗失代偿期肝硬化患者肾血流和血清血管活性因子水平的变化[J]. 实用肝脏病杂志, 2020, 23(5): 707-710.